Immuneering Corporation
USD4.29
+0.00 (+-0.12%)
CEO
Benjamin J. Zeskind
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.30
Prev. Close
$4.29
Day Low
$4.27
Day High
$4.32
52W Low
$2.90
52W High
$10.08
Market Cap
$0.16B
Volume
0.01M
| 0 |
| $0.00 |
| 24 Jun 2026 | Zeskind Benjamin J. | director, officer: PRESIDENT AND CEO | P-Purchase | Acquired | 2,400 | $4.56 |
| 16 Jun 2026 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | P-Purchase | Acquired | 6,035 | $4.15 |
| 11 Jun 2026 | Schall Thomas J. | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | HAUSMAN DIANA | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | CARPENTER ROBERT J | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | KEATING LAURIE | director | A-Award | Acquired | 33,350 | $4.12 |
| 11 Jun 2026 | Feinberg Peter | director | A-Award | Acquired | 33,350 | $4.12 |
| 17 Mar 2026 | Neufeld Leah R | CHIEF PEOPLE OFFICER | A-Award | Acquired | 3,628 | $4.29 |